# Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer

> **NCT00278369** · EARLY_PHASE1 · COMPLETED · sponsor: **Northwestern University** · enrollment: 20 (actual)

## Conditions studied

- Kidney Cancer

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** denileukin diftitox

## Key facts

- **NCT ID:** NCT00278369
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2009-06
- **Final completion:** 2010-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00278369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00278369, "Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00278369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*